Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 
 


Keywords

2025-09-28 07:42:37| The Economic Times

Sun Pharma faces potential impact from the US 100% tariff on patented drugs, which could reduce FY2627 earnings by 810%. Generic drugs remain exempt. The companys innovative portfolio, strong cash position, and mitigation options support steady revenue growth, maintaining HSBCs Buy rating with Rs 1,850 target.


Category: News and Media

 

LATEST NEWS

2025-09-28 07:37:14| The Economic Times

Spirit maker Alcobrew Distilleries India Ltd has filed draft papers with capital markets regulator Sebi to seek its approval to raise funds through an initial public offering (IPO).


Category: News and Media

 

2025-09-28 07:34:48| The Economic Times

The combined market valuation of the top-10 most valued firms eroded by Rs 2,99,661.36 crore last week, in line with a bearish trend in equities, with IT bellwether Tata Consultancy Services taking the biggest hit.


Category: News and Media

 

Latest from this category

28.09Dad-of-three turns to food bank after job loss
28.09'At our library you can borrow drills, telescopes and life jackets'
28.09Stocks to watch this week: Hindustan Copper, NLC India among five picks with potential gains up to 28%
28.09Sun Pharma stares at 8-10% profit risk amid 100% Trump tariffs, says HSBC. Can the giant navigate this?
28.09Alcobrew Distilleries India files draft papers for IPO; eyes Rs 258 cr via fresh issue
28.09Market cap of top-10 most valued firms drops by Rs 2.99 lakh cr; TCS hit hard
28.09Tata Capital: GMP action begins for biggest IPO of 2025. 5 things to know
28.09Eternal vs Swiggy: Which one does HSBC pick as competition intensifies?
News and Media »

All news

28.09Dad-of-three turns to food bank after job loss
28.09'At our library you can borrow drills, telescopes and life jackets'
28.09Stocks to watch this week: Hindustan Copper, NLC India among five picks with potential gains up to 28%
28.09Sun Pharma stares at 8-10% profit risk amid 100% Trump tariffs, says HSBC. Can the giant navigate this?
28.09Alcobrew Distilleries India files draft papers for IPO; eyes Rs 258 cr via fresh issue
28.09Market cap of top-10 most valued firms drops by Rs 2.99 lakh cr; TCS hit hard
28.09Tata Capital: GMP action begins for biggest IPO of 2025. 5 things to know
28.09Eternal vs Swiggy: Which one does HSBC pick as competition intensifies?
More »
Privacy policy . Copyright . Contact form .